Discussing the Impact COVID-19 Has Had on Hemophilia Management and the Major Findings from the 2020 Virtual Meeting

 

In this discussion, the panel discusses the impact COVID-19 has had on hemophilia management. They also review late breaking information presented at the 2020 virtual congress and important initiatives currently underway with the ISTH.

Previous Article Key Findings/Learnings from the 2020 Meeting Related to Anticoagulation
Next Article What Are the Key Takeaways from the State-of-the-Art Session for Guidelines Associated with Diagnosis and Treatment of TTP?
Print

Theme picker